Author

J. A. Enow

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:fluorescence / live-cell microscopy· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

M. M. Rahman· 2 shared A. D. Gutierrez-Jensen· 1 shared A. Everts· 1 shared F. v. Oosterom· 1 shared G. McFadden· 1 shared H. L. Glenn· 1 shared I. B. Hogue· 1 shared J. A. Drewes· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

M. M. Rahman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Live-cell Fluorescence Microscopy of HSV-1 Cellular Egress by Exocytosis

M. H. Bergeman, M. Q. Hernandez, J. Diefenderfer, J. A. Drewes, K. Velarde, W. M. Tierney, J. A. Enow, H. L. Glenn, M. M. Rahman, I. B. Hogue

This study uses live-cell fluorescence microscopy to show HSV-1 exits epithelial cells individually via preferential exocytosis sites, not bulk release, and this process is cell type-dependent and microtubule cytoskeleton-related.

bioRxiv · Feb 27, 2023 · PreprintMicrobiology

A novel anti-cancer therapy with nuclear export inhibitor Selinexor in combination with oncolytic myxoma virus

M. M. Rahman, F. v. Oosterom, J. A. Enow, M. Hossain, A. D. Gutierrez-Jensen, M. Cashen, A. Everts, K. Lowe, J. Kilbourne, J. Daggett-Vondras, T. L. Karr, G. McFadden

This study shows that combining Selinexor with oncolytic myxoma virus enhances virus replication and cancer cell killing in vitro and in vivo.

bioRxiv · Oct 31, 2022 · PreprintMicrobiology